Medicare Enrolled

Dr. Gerardo Capo, MD

Optician · Elizabeth, NJ
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
225 WILLIAMSON ST, Elizabeth, NJ 07202
9089945000
Registered in NPPES since 2006
NPI: 1225049505 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Capo from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Capo? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Capo

Dr. Gerardo Capo is an optician specialist in Elizabeth, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Capo performed 394 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Capo received a total of $43,918 from 54 pharmaceutical and/or device companies across 455 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Capo is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration ▲ 394 Medicare services $43,918 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
394
Medicare services
Bottom 29% in NJ for optician
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
Not available
Unique patients (not deduplicated)
$81
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
207 $67 $189
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
81 $112 $267
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
41 $68 $174
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
30 $51 $123
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
18 $145 $488
New patient office visit, complex (60-74 min) 17 $127 $407
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$43,918
Total received (2018-2024)
Avg $6,274/year across 7 years
Top 5% in NJ for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
54
Companies
455
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,818
2023
$3,999
2022
$4,434
2021
$348
2020
$1,014
2019
$950
2018
$31,355

Payments by company (2024)

GENZYME CORPORATION
$199
AstraZeneca Pharmaceuticals LP
$185
Regeneron Healthcare Solutions, Inc.
$148
Gilead Sciences, Inc.
$121
E.R. Squibb & Sons, L.L.C.
$116
Celgene Corporation
$86
Daiichi Sankyo Inc.
$84
PFIZER INC.
$78
Bayer Healthcare Pharmaceuticals Inc.
$78
Exelixis Inc.
$70
Merck Sharp & Dohme LLC
$59
Lilly USA, LLC
$57
Takeda Pharmaceuticals U.S.A., Inc.
$55
Eisai Inc.
$50
ABBVIE INC.
$46
Dendreon Pharmaceuticals LLC
$44
Novartis Pharmaceuticals Corporation
$41
TAIHO ONCOLOGY, INC.
$38
Aveo Pharmaceuticals, Inc.
$37
GlaxoSmithKline, LLC.
$36
ARRAY BIOPHARMA INC
$34
Biocon Biologics Inc
$20
Janssen Biotech, Inc.
$19
Genentech USA, Inc.
$18
Pharmacosmos Therapeutics Inc.
$18
Apellis Pharmaceuticals, Inc.
$17
Telix Pharmaceuticals
$17
EMD Serono, Inc.
$17
Incyte Corporation
$16
Legend Biotech USA Inc.
$14
Top 3 companies account for 29.3% of 2024 payments
All-time payments by company (2018-2024) ›
Bayer HealthCare Pharmaceuticals Inc.
$31,391
Gilead Sciences, Inc.
$3,738
Regeneron Healthcare Solutions, Inc.
$2,825
E.R. Squibb & Sons, L.L.C.
$550
GENZYME CORPORATION
$478
Daiichi Sankyo Inc.
$432
AstraZeneca Pharmaceuticals LP
$352
Genentech USA, Inc.
$344
Seagen Inc.
$282
PFIZER INC.
$264
Merck Sharp & Dohme Corporation
$262
Celgene Corporation
$251
Lilly USA, LLC
$206
Exelixis Inc.
$194
Merck Sharp & Dohme LLC
$189
Amgen Inc.
$187
Janssen Biotech, Inc.
$144
Incyte Corporation
$131
Dendreon Pharmaceuticals LLC
$117
Bayer Healthcare Pharmaceuticals Inc.
$116
Taiho Oncology, Inc.
$114
Alexion Pharmaceuticals, Inc.
$105
Eisai Inc.
$95
Novartis Pharmaceuticals Corporation
$94
Janssen Scientific Affairs, LLC
$84
TAIHO ONCOLOGY, INC.
$73
Foundation Medicine, Inc.
$70
Takeda Pharmaceuticals U.S.A., Inc.
$70
GlaxoSmithKline, LLC.
$63
Kite Pharma, Inc.
$57
SANOFI-AVENTIS U.S. LLC
$56
EISAI INC.
$56
ABBVIE INC.
$46
Octapharma USA, Inc.
$45
Janssen Pharmaceuticals, Inc
$43
Aveo Pharmaceuticals, Inc.
$37
Seattle Genetics, Inc.
$37
ARRAY BIOPHARMA INC
$34
Global Blood Therapeutics, Inc.
$30
Astellas Pharma US Inc
$27
MACROGENICS, INC.
$22
Biocon Biologics Inc
$20
Pharmacosmos Therapeutics Inc.
$18
Genmab U.S., Inc.
$17
Apellis Pharmaceuticals, Inc.
$17
Telix Pharmaceuticals
$17
EMD Serono, Inc.
$17
Blueprint Medicines Corporation
$16
Epizyme, Inc.,
$15
Otsuka America Pharmaceutical, Inc.
$15
MEDIVATION FIELD SOLUTIONS LLC
$14
Legend Biotech USA Inc.
$14
RECORDATI_RARE_DISEASES_INC.
$13
Boehringer Ingelheim Pharmaceuticals, Inc.
$12
Top 3 companies account for 86.4% of all-time payments
Associated products mentioned in payments ›
ALIMTA · ALUNBRIG · AYVAKIT · Alecensa · Avastin · BOSULIF · Blincyto · CABLIVI · CABOMETYX · CYRAMZA · Cabometyx · DARZALEX · ELAHERE · ELIQUIS · ELITEK · ENHERTU · EPKINLY · ERLEADA · Empaveli · Enhertu · FIBRYGA · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · GAZYVA · GILOTRIF · Herceptin · IBRANCE · ILLUCCIX · IMBRUVICA · IMFINZI · INJECTAFER · Itovebi · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · Kyprolis · LENVIMA · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LYNPARZA · Lenvima · Lonsurf · Lunsumio · MARGENZA · MONJUVI · MONOFERRIC · NINLARO · Nexavar · Nplate · Nubeqa · ONUREG · OPDIVO · OXBRYTA · Ogivri · PADCEV · PIQRAY · POLIVY · PROVENGE · Perjeta · Pomalyst · REBLOZYL · SARCLISA · SOLIRIS · SPRYCEL · SYLVANT · Stivarga · TAGRISSO · TAZVERIK · TECENTRIQ · TECVAYLI · TUKYSA · TUMOR LYSIS SYNDROME - DISEASE · Tivdak · Trodelvy · Turalio · ULTOMIRIS · VERZENIO · Vanflyta · WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) · XALKORI · XARELTO · XOSPATA · XTANDI · Xofigo · Xospata · Yescarta · ZEJULA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for an optician specialist in Elizabeth?
Compare opticians in the Elizabeth area by procedure volume, costs, and industry payment transparency.
Browse opticians nearby

Geographic Context

Opticians in nearby ZIP areas
12,470
County median income
$100,117
Nearest hospital to ZIP centroid (approximate)
NEWARK BETH ISRAEL MEDICAL CENTER
4.1 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Capo is a clinical cardiology specialist, with moderate Medicare volume, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Capo experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Capo performed 207 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Capo receive payments from pharmaceutical companies?
Yes. Dr. Capo received a total of $43,918 from 54 companies across 455 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Capo's costs compare to other opticians in Elizabeth?
Dr. Capo's average Medicare payment per service is $81. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Capo) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →